Advancing global cancer control through data analysis and international collaboration
Official title: CGH - Center for Global Health Data Analysis, Technical Support and Dialogues
Funded at Leidos Biomedical Research, INC. · NIH-11219804 · Data updated 2026-11-12
This study is all about helping countries around the world work better together to fight cancer by sharing important information and training scientists, especially in places that need extra support.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project start | September 28, 2024 |
| Project end | August 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $1,200,000 |
| NIH project number | 75N91019D00024-0-759102400011-26 |
| Project ID | NIH-11219804 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include patients from low- and middle-income countries affected by cancer.
✕Less likely to help
Patients who are not involved in global health initiatives or who do not have access to international cancer control programs may not receive benefits from this research.
What this research studies
This research focuses on enhancing global cancer control efforts by supporting the National Cancer Institute's (NCI) mission. It involves compiling and analyzing data related to global health grant portfolios and producing reports and publications aimed at various stakeholders, including scientists and policymakers. The project also facilitates international partnerships and discussions in oncology, providing training and logistical support for scientists from low- and middle-income countries (LMICs). Through these efforts, the research aims to improve cancer control strategies worldwide.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer control strategies and better health outcomes for patients globally.
How similar studies have gone: Other research initiatives focused on global cancer control and international partnerships have shown success in improving cancer outcomes, indicating that this approach is promising.
Where this research is happening
-
Leidos Biomedical Research, INC.
Frederick, United States Active
Researchers
- Principal investigator: Briscoe, Lynn — Leidos Biomedical Research, INC.
- Study coordinator: Briscoe, Lynn
Related research
Other NIH-funded projects on the same topics.
-
Improving public health responses to COVID-19 through standardized testing.
This study is looking to improve how we fight COVID-19 by testing blood samples to see if people have had the virus, and it’s designed for anyone interested in better ways to manage the disease.
-
Creating a large library of cancer models for research use
This study is creating a collection of new cancer models to help researchers and companies find better ways to treat cancer, making it easier for everyone to work together and share ideas.
-
Support for HIV and HPV cancer prevention clinical trials in the Americas
This study is working on new vaccines and treatments to help prevent cancers related to HIV and HPV, making sure that patients in the US, Latin America, and the Caribbean can access better options as these exciting trials move forward.
-
Development and production of clinical-grade biopharmaceuticals
This study is all about making safe and effective new medicines, like vaccines and treatments for various conditions, so that patients can have access to the latest therapies that meet high-quality standards.
-
Understanding the immune response to COVID-19
This study is looking for ways to improve COVID-19 testing and understand how our immune system fights the virus, and you can help by sharing samples to make these tests better for everyone.
-
Support for operations at the National Cancer Institute in Frederick.
This study is all about helping cancer researchers at the National Cancer Institute work better together, which could lead to better treatments and care for patients like you in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.